Rare diseases
Investigational molecules
Locations
Back to Denmark1 426 clinical trials in Herlev, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
DenmarkStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
DenmarkStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
DenmarkStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
DenmarkStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
DenmarkStudy on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis
DenmarkStudy on Insulin Glargine for Patients with Type 2 Diabetes: Comparing Decentralized, Hybrid, and Standard Clinical Trial Approaches
DenmarkStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
DenmarkStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
DenmarkStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
DenmarkStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
DenmarkStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in endometrial, prostate, and bladder cancers. Studies are evaluating novel combination therapies and immunological approaches.
Research aims to improve treatment outcomes and survival rates through targeted therapeutic approaches.
Comprehensive research into heart failure prevention and treatment of metabolic conditions, including studies on innovative drug combinations and biomarker-targeted approaches.
Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.
Studies examining vaccine effectiveness and preventive treatments, particularly in meningococcal and varicella infections. Research includes both pediatric and adult populations.
Emphasis on developing safe and effective preventive measures for infectious diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
